Cardiac Surgery

Cardiothoracic surgery includes coronary artery bypass surgery (CABG), heart valve repair or replacement, left ventricular assist device (LVAD) placement, heart transplant, assisting in minimally invasive transcatheter valve structural heart procedures such as TAVR, left atrial appendage (LAA) occlusion, septal myectomy, surgical ablation for arrhythmias, and reconstruction of the heart in congenial heart disease cases. 

RSS icon
Jon Kobashigawa, MD, a veteran cardiologist with the Smidt Heart Institute at Cedars-Sinai, is the new president of the American Society of Transplantation (AST).

Cardiologist takes helm of American Society of Transplantation

Jon Kobashigawa, MD, head of the heart transplant program for Smidt Heart Institute at Cedars-Sinai, has been with AST since 2001.

the words "FDA recall" on a board

Abbott’s HeartMate LVADs recalled again over screen issues—FDA highlights significant risks

Abbott has received multiple reports of its HeartMate monitor screens freezing, glitching and even displaying incorrect patient information. A total of 17 injuries have been reported so far. 

Surgeons Operating On Patient

Mechanical valves linked to superior long-term survival after tricuspid valve replacement

Each valve type has its own benefits, researchers noted, but mechanical valves are associated with multiple long-term benefits compared to tissue/bioprosthetic valves. 

Thumbnail

Heart surgeons are fed up with old technology—many have considered a career change

A majority of U.S. surgeons, including those who treat heart patients on a daily basis, say their operating rooms use outdated technology. It is having a negative impact on patient care. 

Elutia, a Maryland-based healthcare technology company, has received clearance from the U.S. Food and Drug Administration (FDA) for EluPro, its new biologic envelope specifically designed for patients with implantable pacemakers and defibrillators. It was also cleared for use when implanting other types of devices, including neurostimulators and neuromodulators.

FDA clears new drug-eluting envelope for implantable cardiac devices—CEO sees it as ‘tip of the iceberg’

Elutia, formerly known as Aziyo Biologics, is already targeting additional uses for the newly approved device. 

Three patient deaths, 31 injuries and 322 complains led to a U.S. Food and Drug Administration Class 1 recall of Teleflex/Arrow International FiberOptix and UltraFlex intra-aortic balloon pump (IABP) catheter kits in April 2024.

Patient deaths and injuries prompt Teleflex to recall intra-aortic balloon catheters

Three patient deaths, 31 injuries and 322 complaints led to an FDA Class 1 recall of Teleflex/Arrow International intra-aortic balloon pump catheter kits.

doctor patient discharge after heart surgery

TAVR vs. SAVR for low-risk patients: Cardiologist explores the decision-making process

While multiple studies have confirmed that TAVR and surgery are associated with comparable outcomes, it is important to take an individualized approach to all treatment decisions.

The Tria surgical mitral valve is built using LifePolymer, a proprietary material that does not include animal tissue. Both the frame of the valve and its leaflets are generated by computer to match each patient’s native mitral valve. According to Foldax, this new-look polymer reduces the long-term risk of valve calcification, and patients should be able to bounce back after surgery without requiring the long-time use of anticoagulants.

New-look polymer mitral valve linked to positive outcomes 30 days after surgery

The new surgical valve from Foldax was designed to limit calcification and make it so patients do not require long-term anticoagulant therapy following treatment. 

Displaying 137 - 144 of 375
Design by Adaptive Theme